Overview
- 13 FDA inspections are on record.
- 4 inspections produced a Form 483.
- The most recent recorded inspection date is 2016-08-10.
At a glance
Inspections
13
Form 483s
4
EIRs
1
Last outcome
Clean
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 8 Aug 2016 – 10 Aug 2016 | Human Drugs | Clean | |
| 14 Aug 2014 – 22 Aug 2014 | Human Drugs | Clean | |
| 18 Mar 2014 – 25 Mar 2014 | Human Drugs | Clean | |
| 20 Sep 2013 – 30 Sep 2013 | Human Drugs | 483 | On file |
| 5 Oct 2012 | Not recorded | Clean | |
| 28 Jun 2011 | Not recorded | 483 | View 483 → |
| 2 Jun 2010 | Not recorded | 483 | View 483 → |
| 9 Sep 2009 | Not recorded | Clean | |
| 20 Oct 2008 | Not recorded | 483 | View 483 → |
| 17 Jan 2008 | Not recorded | Clean | |
| 19 Oct 2006 | Not recorded | Clean | |
| 13 Sep 2004 | Not recorded | Clean | |
Observations on record
Form 483 observations cited at this site, most recent first.
28 Jun 2011
21 CFR 211.192
Investigations of discrepancies, failures
Cited by Stacey S Degarmo, Mary-Jeanet Mcgarry
2 Jun 2010
21 CFR 314.80(c)
Failure by applicant to report ADE
Cited by Debra M Emerson, Stacey S Degarmo
2 Jun 2010
21 CFR 314.80(c)(1)(i)
Late submission of 15-day report
Cited by Debra M Emerson, Stacey S Degarmo
2 Jun 2010
21 CFR 314.80(c)(1)(ii)
Submission of report follow-up
Cited by Debra M Emerson, Stacey S Degarmo
Investigators
FDA investigators tied to this site in the record.
Stacey S Degarmo3 insp.
Debra M Emerson2 insp.
John P Mistler1 insp.
Danielle Pearson1 insp.
Justine M Corson1 insp.
Darin S Wiegers1 insp.
Susanne M Richardson1 insp.
Mary-Jeanet Mcgarry1 insp.
John S Hartford1 insp.
Michelle M Noe1 insp.
Kent A Conforti1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.165(e) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 312.50 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 312.56(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 314.80(c) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 314.80(c)(1)(i) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 314.80(c)(1)(ii) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 314.80(c)(2) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 314.81(b)(1)(ii) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Genzyme Corporation's 4 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat